(Total Views: 306)
Posted On: 03/19/2018 6:31:03 PM
Post# of 72444
I'd prefer the $100/share buyout myself.
Bahahahahaha! Sorry I tried to keep a straight face saying that.
I don't think we'll ever see a dividend here (unless it's a small, one-timer to flush out those nasty naked shorts). With the breadth of our pipeline I think there will always be better uses for any cash we have. Imbruvica was running 13 phase 3 trials when it was acquired and that was a tightly focused blood cancer drug. Between B and P we're looking at potential Humira-like versatility.
Now, if we get to the point where we're running dozens of phase 3 trials and still overflowing with cash...well, most of us won't care about a dividend at that point.
Go IPIX!
Bahahahahaha! Sorry I tried to keep a straight face saying that.
I don't think we'll ever see a dividend here (unless it's a small, one-timer to flush out those nasty naked shorts). With the breadth of our pipeline I think there will always be better uses for any cash we have. Imbruvica was running 13 phase 3 trials when it was acquired and that was a tightly focused blood cancer drug. Between B and P we're looking at potential Humira-like versatility.
Now, if we get to the point where we're running dozens of phase 3 trials and still overflowing with cash...well, most of us won't care about a dividend at that point.
Go IPIX!
(1)
(0)
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.
